Intignus Biotech retweetledi

Five startups. One global opportunity.
From an exceptional cohort of twelve startups in the BFI VK Connect program, five biomedical innovators have earned the opportunity to establish their presence within the European healthcare ecosystem.
Through this initiative, these startups will gain access to strategic partnerships, market entry pathways, and networks that can accelerate their journey toward global impact.
Meet the five startups taking this step forward:
ForschMedX
Abhishek Gaikar, Founder & CEO
TrachEase – An automated airway management system that combines a modified endotracheal tube, smart suction, and real time obstruction detection to clear airway secretions in ventilated patients.
CrisprBits
Kruthika B S, Principal Scientist and Manoti Tare, Lead, Business Operations
PathCrisp MicroDetect-AMR – A CRISPR-based point-of-care diagnostic that uses portable PCR and rapid detection to identify pathogens and antimicrobial resistance markers directly from blood culture.
Intignus Biotech
Vaishnavi Kulkarni, Founder & CEO and Disha Honwad, Clinical Research & Business Development Manager
PEscreen – A rapid, low cost (<15 min) LFA-based screening test that predicts preeclampsia risk, supported by a digital care management platform called WiseMother.
Open MedLabs
Deval Karia, Founder & CEO and Dharaniya Natarajan, Program Manager
Drug Delivery Pump Engine – A precision (<3% error), low cost continuous subcutaneous drug delivery platform powering devices like InsuFlo and adaptable for multiple therapies.
Aignosis Artificial Intelligence
Divyansh Mangal, Co-founder & Director and Raksheet Jain, Co-founder & Director
Aignosis – An AI-powered developmental screening platform using eye tracking and behavioral analytics for early detection of neurodevelopmental conditions such as autism.
By connecting Indian innovators with international stakeholders, BFI VK Connect is enabling promising healthcare solutions to scale beyond borders.

English

















